ArticleMetallomics : integrated biometal science2025
Characterization of a mechanistic connection between persulfide transfer and ATP hydrolysis in the SufBC2D scaffold of the Suf Fe-S cluster assembly pathway.
Article in Metallomics : integrated biometal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The structure of the SufBCbioRxiv : the preprint server for biology · 2026Article
- Intricacies in iron-sulfur cluster function and biogenesis: functional versatility, sulfur sources, and enzyme specificity.RSC chemical biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The Suf pathway is the most common pathway for bacterial iron-sulfur cluster assembly and uses the SufBC2D complex as a scaffold for cluster formation. In most Gram-negative bacteria, the SufB subunit of SufBC2D accepts a persulfide from the transpersulfurase, SufE, for incorporation into nascent clusters. There is no reported structure for the SufBC2D-E complex and mechanistic details concerning the coordination of persulfide delivery with other SufBC2D activities are unclear. Using the Suf pathway from Escherichia coli as a model system, we report that SufE acts as a noncompetitive inhibitor of SufBC2D ATPase activity with a Ki value of 1.8 ± 0.2 µM. This value corresponds with a KD value of 1.6 ± 0.2 µM for SufE binding to the SufBC2D complex determined by fluorescence polarization. The rate of persulfide transfer from SufE to SufBC2D is impaired in the presence of ATP, suggesting that the two reactions are mutually exclusive. An AlphaFold3 model of the SufBC2D-E complex predicts electrostatic interactions between acidic residues on SufC and basic residues on the N-terminal helix of SufE. SufE variants at the K9 and R16 positions interfere with the ability of SufE to transfer persulfide to SufBC2D and to inhibit SufBC2D ATPase activity. In vivo complementation growth assays show that these SufE variants exhibit a slow-growth phenotype under iron starvation conditions, confirming the connection between SufE and SufC as important for optimal function in the Suf pathway. The mutual exclusivity of persulfide delivery from SufE and SufBC2D ATPase activity suggests an ordered mechanism for cluster assembly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.